Dynavax Technologies Corporation (NASDAQ: DVAX) on June 21, 2022, started off the session at the price of $10.46, soaring 6.98% from the previous trading day. During the day, the shares moved up to $11.47 and dropped to $10.46 before settling in for the closing price of $10.31. Within the past 52 weeks, DVAX’s price has moved between $7.26 and $21.39.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
A company in the Healthcare sector has jumped its sales by 108.90% annually for the last half of the decade. The company achieved an average annual earnings per share of 172.60%. With a float of $116.23 million, this company’s outstanding shares have now reached $124.56 million.
In an organization with 311 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +60.28, operating margin of +30.43, and the pretax margin is +17.74.
Dynavax Technologies Corporation (DVAX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Dynavax Technologies Corporation is 0.20%, while institutional ownership is 81.50%. The most recent insider transaction that took place on May 17, was worth 60,000. In this transaction Principal Accounting Officer of this company sold 6,000 shares at a rate of $10.00, taking the stock ownership to the 3,854 shares. Before that another transaction happened on Mar 03, when Company’s President & COO sold 41,862 for $10.57, making the entire transaction worth $442,481. This insider now owns 73,213 shares in total.
Dynavax Technologies Corporation (DVAX) Latest Financial update
As on 3/30/2022, Multinational firm has announced its last quarter scores, in which it reported $0.22 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.24) by -$0.02. This company achieved a net margin of +16.51 while generating a return on equity of 51.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 172.60% per share during the next fiscal year.
Dynavax Technologies Corporation (NASDAQ: DVAX) Trading Performance Indicators
Dynavax Technologies Corporation (DVAX) is currently performing well based on its current performance indicators. A quick ratio of 1.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.87. Likewise, its price to free cash flow for the trailing twelve months is 5.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.52, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 0.69 in one year’s time.
Technical Analysis of Dynavax Technologies Corporation (DVAX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.91 million. That was better than the volume of 2.39 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.75%. Additionally, its Average True Range was 0.83.
During the past 100 days, Dynavax Technologies Corporation’s (DVAX) raw stochastic average was set at 59.84%, which indicates a significant increase from 38.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.51% in the past 14 days, which was lower than the 75.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.34, while its 200-day Moving Average is $13.52. However, in the short run, Dynavax Technologies Corporation’s stock first resistance to watch stands at $11.51. Second resistance stands at $12.00. The third major resistance level sits at $12.52. If the price goes on to break the first support level at $10.50, it is likely to go to the next support level at $9.98. The third support level lies at $9.49 if the price breaches the second support level.
Dynavax Technologies Corporation (NASDAQ: DVAX) Key Stats
Market capitalization of the company is 1.35 billion based on 126,312K outstanding shares. Right now, sales total 439,440 K and income totals 76,710 K. The company made 113,990 K in profit during its latest quarter, and 32,860 K in sales during its previous quarter.